Baker McKenzie advised Ariceum Therapeutics on the deal. Ariceum Therapeutics (Ariceum) completed a EUR 25 million Series A financing round, co-led by EQT Life Sciences (formerly LSP) […]
Ariceum Therapeutics’ Serie A Financing Round
Tubulis’ €60 Million Series B Financing Round
CMS advised Tubulis on the deal, Baker McKenzie advised Andera Partners, Evotec and Fund+ on the deal. Biotech company Tubulis has successfully completed a Series B […]
Allecra Therapeutics’ Licensing Agreement with Advanz Pharma
Baker McKenzie advised Allecra Therapeutics on the deal. Allecra Therapeutics signed an exclusive licensing agreement with Advanz Pharma Corp. Limited, a specialty pharmaceutical company with a strategic […]